ATWOOD & PALMER INC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 130 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
ATWOOD & PALMER INC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$88
-12.9%
2250.0%0.00%
Q2 2023$101
-45.4%
2250.0%0.00%
Q1 2023$185
-47.3%
2250.0%0.00%
Q4 2022$3512250.0%0.00%
Q3 2022$02250.0%0.00%
Q2 2022$0
-100.0%
2250.0%0.00%
Q1 2022$1,0000.0%2250.0%0.00%
Q4 2021$1,000
-50.0%
2250.0%0.00%
Q3 2021$2,0000.0%2250.0%0.00%
Q2 2021$2,0000.0%2250.0%0.00%
Q1 2021$2,0000.0%2250.0%0.00%
Q4 2020$2,000
-33.3%
2250.0%0.00%
Q3 2020$3,000
-50.0%
2250.0%0.00%
-100.0%
Q2 2020$6,000
+200.0%
2250.0%0.00%
Q1 2020$2,000
+100.0%
2250.0%0.00%
Q4 2019$1,0002250.0%0.00%
Q3 2019$0
-100.0%
2250.0%0.00%
Q2 2019$1,0000.0%2250.0%0.00%
Q1 2019$1,0000.0%2250.0%0.00%
Q4 2018$1,0000.0%2250.0%0.00%
Q3 2018$1,0002250.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 200,000$998,0000.36%
Green Alpha Advisors, LLC 72,647$363,0000.24%
Skaana Management L.P. 227,851$1,137,0000.18%
SEVEN EIGHT CAPITAL, LP 196,351$980,0000.18%
Defender Capital, LLC. 103,038$514,0000.16%
Skaana Management L.P. 206,300$1,029,0000.16%
WASATCH ADVISORS LP 4,926,125$24,581,0000.10%
Parametrica Management Ltd 16,183$81,0000.08%
Cedar Brook Financial Partners, LLC 54,500$272,0000.07%
Hennion & Walsh Asset Management, Inc. 274,703$1,371,0000.07%
View complete list of INOVIO PHARMACEUTICALS INC shareholders